Systematic review / meta-analysis / 2020
Acute mycoprotein intake decreases insulin levels and reduces energy intake in humans, while its effect on blood glucose remains unclear.
A systematic review evaluated five acute randomised controlled trials with a total of 122 participants to determine the effects of mycoprotein on glycaemic control and energy intake. The results did not show a clear effect of acute mycoprotein on blood glucose levels, but indicated a decrease in insulin levels. Additionally, acute mycoprotein intake decreased energy intake at an ad libitum meal and post-24 h in healthy lean, overweight, and obese humans. The authors noted that evidence comes from a very limited number of heterogeneous studies.
- Study type
- Systematic review of randomised controlled trials
- Who was studied
- 122 participants across 5 acute studies (healthy lean, overweight, and obese humans)
- What was measured
- Glycaemic control (glycaemia, insulinaemia) and energy intake
THE PAPER
Effects of mycoprotein on glycaemic control and energy intake in humans: a systematic review.
Cherta-Murillo A, Lett AM, Frampton J, Chambers ES, Finnigan TJA, Frost GS. Br J Nutr, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.